Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Zomedica Pharmaceuticals Corp (NY: ZOM )

0.2127 +0.0096 (+4.73%)
Official Closing Price Updated: 8:00 PM EDT, Mar 21, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 7,085,792
Open 0.2125
Bid (Size) 0.2100 (50)
Ask (Size) 0.2127 (1)
Prev. Close 0.2031
Today's Range 0.2065 - 0.2200
52wk Range 0.1500 - 0.4100
Shares Outstanding 979,949,668
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Why Shares of Zomedica Were Zooming Monday
Investors bought back into the stock after it fell to its lowest point in two months. 
Via The Motley Fool
Zomedica Appoints New Chief Financial Officer
Via ACCESSWIRE

Performance

YTD
+32.61%
+32.61%
1 Month
-15.09%
-15.09%
3 Month
+28.06%
+28.06%
6 Month
-7.56%
-7.56%
1 Year
-35.55%
-35.55%

More News

Read More
Zomedica Corporation Reports 2022 Results: $18.9 Million Revenue; 72% Gross Margin & $156 Million in Liquidity - Revenue up 361% from 2021 through combination of acquisitions and organic growth
Via ACCESSWIRE
Zomedica to Host Fourth Quarter and Fiscal Year 2022 Financial Results Call on March 15
Via ACCESSWIRE
Zomedica Reports Preliminary Results for the Fourth Quarter and Full Year 2022
Via ACCESSWIRE
Zomedica Interview To Air on Bloomberg U.S. on the RedChip Money Report(R)
Via ACCESSWIRE
Earnings Scheduled For March 15, 2023
Via Benzinga
RedChip CEO Dave Gentry Invited to Join Forbes Business Council
Via ACCESSWIRE
Zomedica to Participate in the Lytham Partners Investor Select Conference
Via ACCESSWIRE
PRTY Stock Alert: NYSE Halts Trading in Party City Amid Bankruptcy News
Via InvestorPlace
Why Is Zomedica (ZOM) Stock Up Today?
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
Zomedica to Take Control of New Assay Development and Manufacturing of TRUFORMA Product Line through Long-Term Licensing Agreement with Qorvo Biotechnologies
Via ACCESSWIRE
Zomedica Expands Relationship with Structured Medical Products and Begins Commercializing VetGuardian Wireless Monitors
Via ACCESSWIRE
Zomedica to Present at Sidoti Virtual Investor Conference January 18-19
Via ACCESSWIRE
Zomedica CEO Interview with Wall Street Analyzer Updates Company Progress and Plans
Via ACCESSWIRE
Zomedica Announces Third Quarter 2022 Financial Results: $4.78 Million Revenue; 75% Gross Margin & $158.49 Million in Cash, Cash Equivalents, and Available-For-Sale Securities
Via ACCESSWIRE
Why Spruce Biosciences Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
10 Best Medical Stocks Under $5
Via Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For January 6, 2023
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Zomedica to Present at LD Micro Main Event XV Conference
Via ACCESSWIRE
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
Zomedica To Present at Dawson James Securities 7th Annual Small Cap Growth Conference
Via ACCESSWIRE
Zomedica Announces Launch of Free T4 Assay for Truforma(R) Diagnostic Platform
Via ACCESSWIRE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.